Skip to main content
. 2021 Jul 12;41(7):BSR20211115. doi: 10.1042/BSR20211115

Table 2. Relationship between clinicopathological characteristics and UCA1 and PGM5-AS1 expression (n=188).

Variable Cases UCA1 P-value* PGM5-AS1 P-value*
Median with interquartile range Median with interquartile range
Age
<60 65 2.789 (1.474–4.634) 0.279 1.275 (0.785–1.840) 0.684
≥60 123 3.639 (1.434–4.170) 1.223 (0.780–1.778)
Gender
Male 106 2.594 (1.331–4.042) 0.441 1.117 (0.731–1.778) 0.662
Female 82 3.010 (1.566–4.580) 1.324 (0.989–1.850)
Differentiation
Well 87 2.338 (1.425–3.925) 0.208 1.218 (0.773–1.759) 0.898
Moderate+Poor 101 2.819 (1.464–4.619) 1.253 (0.803–1.840)
AJCC stage
I + II 128 2.639 (1.459–4.077) 0.904 1.137 (0.776–1.600) 0.064
III + IV 60 2.858 (1.444–4.402) 1.532 (0.844–2.014)

*P-values are based on unpaired samples t test.